News

UBS-AM invests £66m in new life sciences facility for cancer therapies

By 2021-11-08T10:50:00

2021-07-07 View_02 Dusk copy email

UBS Asset Management Real Estate & Private Markets has provided £66m in forward funding for a pharmaceutical facility in Stevenage, pre-let to Autolus Therapeutics on a 20-year lease.

UBS are working with development partner Reef Estates, who will develop the site with Merit Health as the underlying contractor. Stevenage Borough Council is the vendor.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.

Registered users and subscribers SIGN IN here to continue